Tamsulosin Completed Phase N/A Trials for Prostatic Hyperplasia

IndicationsStatusPurposePhase
CompletedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01386983Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment
NCT01390870Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence
NCT02244268Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic Hyperplasia
NCT02244346Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)
NCT02244320Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)
NCT02245555Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia
NCT02245529Safety Profile of Secotex ® in Patients With Benign Prostatic Hyperplasia
NCT02245503Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH)